@inproceedings{inproceedings, title  = {{Progressive and sustained Disease Control in Patients with atopic Dermatitis (AD) aged 12 to 17 Years treated with Tralokinumab for 52 Weeks}},

 url = {{}},

 year = {{2024}},

 month = {{1}},

 author = {{Wollenberg A and Cork M and Chih-ho-Hong H and Kurbasic A and Vacko E and Paller AS}},

 volume = {{47}},

 journal = {{ALLERGOLOGIE}},

 issue = {{9}},

 note = {{Accessed on 2024/12/22}}}